Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer.

Journal for immunotherapy of cancer·2024

Same author

XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors as Evidenced by Preclinical Studies.

Molecular cancer therapeutics·2023

Same author

A Study Design to Harmonize Patient-Reported Outcomes Across Data Sets.

JCO clinical cancer informatics·2023

Same author

Discovery of a chemical probe for PRDM9.

Nature communications·2019

Same author

Identification of Kinases Responsible for p53-Dependent Autophagy.

iScience·2019

Same author

A Potent and Selective ULK1 Inhibitor Suppresses Autophagy and Sensitizes Cancer Cells to Nutrient Stress.

iScience·2018

Search research articles

Related Experiment Video

Updated: May 30, 2026

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

KRAS Mouse Models: Modeling Cancer Harboring KRAS Mutations.

Rónán C O'Hagan¹, Joerg Heyer

¹AVEO Pharmaceuticals, Cambridge, MA, USA.

|July 23, 2011

Summary

Genetically engineered mouse models are crucial for understanding KRAS-driven cancers. These models improve insights into cancer biology and therapeutic interventions for KRAS-dependent oncogenesis.

Keywords:

interpatient tumor variation mouse models harboring KRAS mutation tumor context tumor genetics

More Related Videos

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models

Published on: February 3, 2026

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Published on: March 26, 2014

Related Experiment Videos

Last Updated: May 30, 2026

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models

Published on: February 3, 2026

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Published on: March 26, 2014

Area of Science:

Oncology
Genetics
Cancer Biology

Background:

KRAS is a significant oncogene, mutated in approximately 30% of human cancers.
The precise biological context of KRAS-driven oncogenesis remains incompletely understood.
Genetically engineered mouse models are vital for dissecting cancer development.

Purpose of the Study:

To review progress in modeling KRAS-dependent cancers.
To highlight the impact of these models on understanding cancer biology.
To emphasize the importance of accurate models for translational research.

Main Methods:

Utilizing genetically engineered mouse models to study KRAS-driven oncogenesis.
Analyzing tumor variation in mouse models to understand therapeutic response and resistance.
Focusing on models that recapitulate human tumor genetics and tumor-stromal interactions.

Main Results:

Insights from KRAS-driven mouse models have advanced the understanding of oncogenic processes.
These models reveal genetic, cellular, and tissue contexts critical for KRAS oncogenesis.
Tumor variation in models offers insights into therapy resistance mechanisms.

Conclusions:

Accurate KRAS-driven cancer models are essential for reflecting human tumor genetics.
Recapitulating complex tumor-stromal intercommunication in models is critical.
Advanced models facilitate translational insights into therapeutic strategies for KRAS-dependent cancers.